Reduced-intensity conditioned allogeneic haematopoietic transplantation in an adult with Langerhans cell histiocytosis and thrombocytopenia with absent radii [3]

Bone Marrow Transplantation

Volumn 37, Issue 7, 2006, Pages 713-715

  Ingram, W ^a   Desai, S R ^a   Gibbs, J S R ^b   Mufti, G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BUSULFAN; FLUDARABINE;

ADULT; AIRWAY OBSTRUCTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE DISEASE; BONE SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HISTIOCYTOSIS; HUMAN; HUMAN CELL; LANGERHANS CELL; LETTER; LUNG DISEASE; LUNG FUNCTION TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS FRACTURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RADIUS APLASIA; REDUCED INTENSITY CONDITIONING; THROMBOCYTOPENIA;

ADULT; APNEA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; RADIUS; SENSITIVITY AND SPECIFICITY; THROMBOCYTOPENIA; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33645243379     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705300     Document Type: Letter

References (10)

1. Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 2000; 342: 1969-1978.
2. Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H. Response to initial treatment of multisystem Langerhans cell histiocytosis: An important prognostic indicator. Med Pediatr Oncol 2002; 39: 581-585.
3. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Fdmonson JH, Schomberg PJ. Langerhans cell histiocytosis: Diagnosis, natural history, management, and outcome. Cancer 1999; 85: 2278-2290.
4. Akkari V, Donadieu J, Piguet C, Bordigoni P, Michel G, Blanche S et al. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: Experience of the French Langerhans cell study group. Bone Marrow Transplant 2003; 31: 1097-1103.
5. Kinugawa N, Imashuku S, Hirota Y, Yamada K, Yamamoto A, Akazai A et al. Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan. Bone Marrow Transplant 1999; 24: 935-938.
6. Steiner M, Matthes-Martin S, Attarbaschi A, Minkov M, Grois N, Unger F et al. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 2005; 36: 215-225.
7. Jordan MB, McClain KL, Yan X, Hicks J, Jaffe R. Anti-CD52 antibody, alemtuzumab, binds to Langerhans cells in Langerhans cell histiocytosis. Pediatr Blood Cancer 2005; 44: 251-254.
8. Ng CS, Desai SR, Rubens MB, Padley SP, Wells AU, Hansell DM. Visual quantitation and observer variation of signs of small airways disease at inspiratory and expiratory CT. J Thorac Imaging 1999; 14: 279-285.
9. Vassallo RRJ, Colby T, Hartman T, Limper A. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 2005; 342: 1969-1978.
10. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 2002; 346: 484-490.